AI/ML Innovations Secures U.S. Patent for ECG Signal-Processing Technology

AI/ML Innovations Inc., a leader in AI-powered physiological signal interpretation, has been granted a U.S. patent for its core ECG signal-processing architecture. This patent validates AIML's neural-network approach for denoising and mapping ECG signals, enhancing products like MaxYield™ and CardioYield™. The technology's ability to extract clinically useful data from ECG signals boosts the company's competitive edge as they advance commercialization and regulatory strategies.

The company highlights that the new patent supports its intellectual property position, aligning with its clinical validation, regulatory, and commercial efforts. The grant reflects significant progress, offering broad protection for their innovative architecture. AIML continues to expand its intellectual property portfolio to accelerate global product deployment.